In breast cancer, KLF17 was identified as a metastasis suppressor, counteracting EMT in the 168FARN murine breast cancer cell line, normal murine (nMuMG) and human (HMLE) breast epithelium [55]. The gene discussed is KLF17; the disease is breast carcinoma.